• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Coronary angioplasty safe and effective at facilities without on-site cardiothoracic surgery

byRehan SaiyedandChaz Carrier
September 12, 2014
in Cardiology, Emergency
Reading Time: 3 mins read
Ultrasound, flow reserve guided coronary interventions provide minimal benefit
Share on FacebookShare on Twitter

1. Rates of procedural complications, one-year mortality, and myocardial infarction were equivalent between individuals undergoing coronary angioplasty at facilities with and without on-site cardiothoracic surgery.

2. Patients undergoing coronary angioplasty at facilities without on-site cardiothoracic surgery were at a higher risk for subsequent unplanned revascularization within one year of a surgery.

Evidence Rating Level: 2 (Good)           

Study Rundown: Recent randomized clinical trials have demonstrated that coronary angioplasty, also known as percutaneous coronary intervention (PCI), can be performed in facilities without onsite cardiothoracic (CT) surgery without adverse effects on the procedure. However, concern remains over the level of oversight required to maintain equivalent safety and efficacy standards. This study objectively compared the outcomes of PCI performed with on-site CT surgery to those without. The authors found equivalent rates of procedural complications, one-year mortality, and one-year myocardial infarction (MI). This supports the safety and long-term effectiveness of PCI performed at facilities without on-site CT surgery. Notably, a higher number of patients treated at a facility without CT surgery underwent unplanned revascularization within one year. Although initially concerning, a higher rate of high-risk stenosis and complete total occlusion (CTO) patients were treated at facilities without on-site CT surgery, which may help to explain this trend. A limitation of this study is that the patient population is from the VA healthcare delivery system, a relatively homogeneous population, which restricts the generalizability of its findings.

Click to read the study in Circulation

Relevant Reading: Percutaneous Coronary Intervention at Centers With and Without On-site Surgery: A Meta-analysis

RELATED REPORTS

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

2 Minute Medicine Rewind December 29th, 2025

In-Depth [retrospective cohort]: A total of 24,387 patients at 59 VA facilities underwent PCI between October 2007 and September 2010. 6,616 patients underwent PCI at facilities without on-site CT surgery and 17,771 at facilities with on-site CT surgery. Patients undergoing PCI at facilities without on-site CT surgery had lower rates of past MI, cardiac risk factors, and non-cardiac co-morbidities as well as higher rates of high-risk (Type C) stenosis and CTO. These patients (40.2%) were also more likely to undergo PCI for elective indications than those at facilities with on-site CT surgery (37.8%). No change in rates of procedural complications and in-lab death were noted across both groups (p = 0.382, p = 0.618, respectively). There was no difference one year mortality (HR 0.96, 95% CI 0.78-1.18) or MI (HR 1.11, 95% CI 0.91-1.34) between facilities with and without on-site CT surgery. This equivalence in risk for one year mortality and MI was maintained when patients were stratified on the basis for their indication for surgery: elective, ST elevation MI (STEM) and non-ST elevation (STEMI). Patients undergoing PCI at facilities without CT surgery were at increased risk of a subsequent PCI (HR 1.27, 95% CI 1.05-1.51) within one year.

More from this author: Artificial turf may increase risk of anterior cruciate ligament injury, Radiofrequency ablation may treat gastric antral vascular atresia, Tumor response ratio may predict survival following neoadjuvant chemotherapy in breast cancer

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: myocardial infarctionPCI
Previous Post

Benzodiazepine use linked with Alzheimer’s disease

Next Post

GLP-1 agonist and basal insulin an effective anti-diabetic regimen

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

January 12, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Admission may not be needed following sleep apnea surgery
Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Next Post
Preterm birth associated with elevated plasma insulin levels

GLP-1 agonist and basal insulin an effective anti-diabetic regimen

Half of parents aware of CT radiation cancer risk

Improved diagnosis of incidental adrenal masses by dual-energy CT

Women electing abortion more likely to be victims of domestic violence

Zofran bests Diclegis for pregnancy-associated nausea

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Robotic cholecystectomy benefits high-risk and higher-BMI patients but costs more
  • Antibiotics after appendectomy were not associated with reduced postoperative infections
  • Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.